DoseMe

Bayesian dosing is a unique way of calculating an indvidualized dose for any patient, resulting in significant improvements to mortality and risk.

Bayesian dosing uses patient data and laboratory results to estimate a patient’s ability to absorb, process, and clear a drug from their system.

DoseMe Cohere is a predictive analytics dashboard for vancomycin monitoring that quickly and easily identifies patients who require intervention.

The page shares success stories from healthcare providers using DoseMeRx.

DoseMe – the world’s first company to design a precision dosing platform for clinical use – has been selected to present at the 2018 BIO International Convention - the world's largest global gathering of biotech and pharma businesses from June 4-7 in Boston, Massachusetts.

DoseMe – the world’s first company to design a precision dosing platform for clinical use – will attend and exhibit at the 23rd European Association of Hospital Pharmacists Congress from March 21-23 2018 in Gothenburg, Sweden.

The page introduces experts advising DoseMeRx on clinical excellence and governance.

The page highlights DoseMeRx leaders working to advance Bayesian dosing.

DoseMeRx uses Bayesian dosing to streamline workflows for clinical pharmacists.

DoseMeRx offers a dosing calculator integrated with EHRs to predict optimal medication doses from one blood sample.

DoseMeRx is committed to maintaining the integrity and security of hospital and patient data.

The page describes DoseMeRx’s compliance with the General Data Protection Regulation (GDPR) and privacy requests.

The notice outlines user rights under the Health Insurance Portability and Accountability Act (HIPAA).

The page explains how DoseMe handles user information as a company.

The DoseMe App aids qualified medical staff in dosing recommendations without providing medical advice.